A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus

NCT05110846 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight
Type 2 Diabetes Mellitus

Interventions

DRUG: Placebo
DRUG: CT-868

Sponsor

Carmot Therapeutics, Inc.

Collaborators

[object Object]